The investigation of IL-2R functionality on the RCC cell lines was first performed using the BrdU incorporation assay, an accurate method for detecting cell proliferation via direct measurement of new DNA synthesis and corresponding cell cycling. The gene discussed is IL2RA; the disease is renal cell carcinoma.